Literature DB >> 20517612

[Ocular involvement in connective tissue diseases and vasculitides].

C Deuter1, I Kötter.   

Abstract

Connective tissue diseases and systemic vasculitides are commonly associated with ocular manifestations, which can lead to severe complications and even blindness. The present review article describes these ocular manifestations, their signs and symptoms and possible treatment options for Sjoegren's syndrome, systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APLS), as well as those of giant cell arteritis/cranial arteritis, ANCA-associated vasculitides and Behçet's disease. Additionally, possible ocular adverse effects of antimalarial agents are described.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20517612     DOI: 10.1007/s00393-009-0579-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  16 in total

Review 1.  Clinical manifestations and early diagnosis of Sjögren syndrome.

Authors:  Stuart S Kassan; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2004-06-28

2.  EULAR recommendations for the management of Behçet disease.

Authors:  G Hatemi; A Silman; D Bang; B Bodaghi; A M Chamberlain; A Gul; M H Houman; I Kötter; I Olivieri; C Salvarani; P P Sfikakis; A Siva; M R Stanford; N Stübiger; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2008-01-31       Impact factor: 19.103

Review 3.  Ocular manifestations of systemic lupus erythematosus.

Authors:  John B Davies; Prabakar Kumar Rao
Journal:  Curr Opin Ophthalmol       Date:  2008-11       Impact factor: 3.761

Review 4.  [Current treatment for dry eye syndrome].

Authors:  C Cursiefen; C Jacobi; T Dietrich; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

5.  How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?

Authors:  A A Achkar; J T Lie; G G Hunder; W M O'Fallon; S E Gabriel
Journal:  Ann Intern Med       Date:  1994-06-15       Impact factor: 25.391

Review 6.  [Ocular findings and differential diagnoses in giant cell arteritis (Arteriitis cranialis)].

Authors:  D Schmidt; T Ness
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

7.  Factors associated with chloroquine-induced retinopathy in rheumatic diseases.

Authors:  R Araiza-Casillas; F Cárdenas; Y Morales; M H Cardiel
Journal:  Lupus       Date:  2004       Impact factor: 2.911

Review 8.  [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment].

Authors:  T Ness; C Auw-Hädrich; D Schmidt
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

Review 9.  Ocular manifestations of systemic lupus erythematosus.

Authors:  R R Sivaraj; O M Durrani; A K Denniston; P I Murray; Caroline Gordon
Journal:  Rheumatology (Oxford)       Date:  2007-08-05       Impact factor: 7.580

10.  Therapy: Hydroxychloroquine in SLE: old drug, new perspectives.

Authors:  Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.